Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shipra Malhotra

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|June 28, 2017
Correction to When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?Shipra Malhotra, John Karanicolas
Journal of Medicinal Chemistry|December 17, 2016
When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?Shipra Malhotra, John Karanicolas
Chemical Biology & Drug Design|January 30, 2014
Two- and three-dimensional rings in drugsMatteo Aldeghi, Shipra Malhotra, David L Selwood, et al.
The Journal of Biological Chemistry|November 10, 2020
A clinically relevant polymorphism in the Na<sup>+</sup>/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat positionMelissa J Ruggiero, Shipra Malhotra, Aron W Fenton, et al.
International Journal of Molecular Sciences|March 25, 2022
Structural Plasticity Is a Feature of Rheostat Positions in the Human Na<sup>+</sup>/Taurocholate Cotransporting Polypeptide (NTCP)Melissa J Ruggiero, Shipra Malhotra, Aron W Fenton, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 5, 2023
SUMO: In Silico Sequence Assessment Using Multiple Optimization ParametersAndreas Evers, Shipra Malhotra, Wolf-Guido Bolick, et al.
European Journal of Medicinal Chemistry|September 30, 2019
Discovery of novel, potent, isosteviol-based antithrombotic agentsPeng Chen, Dianwen Zhang, Meng Li, et al.
Journal of Medicinal Chemistry|April 26, 2019
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)Sean W Reilly, Aladdin A Riad, Chia-Ju Hsieh, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small MoleculesMariam Ahmed Fouad, Christopher S Parry, Sven A Miller, et al.
Nature Biotechnology|November 4, 2024
AIntibody: an experimentally validated in silico antibody discovery design challengeM Frank Erasmus, Laura Spector, Fortunato Ferrara, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|June 28, 2017
Correction to When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?Shipra Malhotra, John Karanicolas
Journal of Medicinal Chemistry|December 17, 2016
When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?Shipra Malhotra, John Karanicolas
Chemical Biology & Drug Design|January 30, 2014
Two- and three-dimensional rings in drugsMatteo Aldeghi, Shipra Malhotra, David L Selwood, et al.
The Journal of Biological Chemistry|November 10, 2020
A clinically relevant polymorphism in the Na<sup>+</sup>/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat positionMelissa J Ruggiero, Shipra Malhotra, Aron W Fenton, et al.
International Journal of Molecular Sciences|March 25, 2022
Structural Plasticity Is a Feature of Rheostat Positions in the Human Na<sup>+</sup>/Taurocholate Cotransporting Polypeptide (NTCP)Melissa J Ruggiero, Shipra Malhotra, Aron W Fenton, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 5, 2023
SUMO: In Silico Sequence Assessment Using Multiple Optimization ParametersAndreas Evers, Shipra Malhotra, Wolf-Guido Bolick, et al.
European Journal of Medicinal Chemistry|September 30, 2019
Discovery of novel, potent, isosteviol-based antithrombotic agentsPeng Chen, Dianwen Zhang, Meng Li, et al.
Journal of Medicinal Chemistry|April 26, 2019
Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Ligand Promiscuity across Highly Conserved Aminergic G-Protein-Coupled Receptors (GPCRs)Sean W Reilly, Aladdin A Riad, Chia-Ju Hsieh, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Rescuing the Function of Missense-Mutated Tumor Suppressor <i>VHL</i> using Stabilizing Small MoleculesMariam Ahmed Fouad, Christopher S Parry, Sven A Miller, et al.
Nature Biotechnology|November 4, 2024
AIntibody: an experimentally validated in silico antibody discovery design challengeM Frank Erasmus, Laura Spector, Fortunato Ferrara, et al.
Pageof 1